2
Announcements
Trials
Browse
Landscape
Status
Completed
2
Sponsor Class
INDUSTRY
2
Study Type
Observational
2
Sponsor
Conditions
Multiple Sclerosis
2
Carcinoma in Situ
2
Sarcoma, Kaposi
1
Multiple Sclerosis, Relapsing-Remitting
1
Multiple Sclerosis, Chronic Progressive
1
HIV Infections
1
Acquired Immunodeficiency Syndrome
1
Interventions
fludarabine
4
Cyclophosphamide
4
Specimen Handling
2
Nivolumab
2
Natalizumab
2
Interferon beta-1b
2
Fingolimod Hydrochloride
2
Blood Specimen Collection
2
teriflunomide
1
nabiximols
1
gadobutrol
1
gadobenic acid
1
cabozantinib
1
Surveys and Questionnaires
1
Respiratory Therapy
1
Registries
1
Platinum Compounds
1
Platelet Transfusion
1
Plasma Exchange
1
Phlebotomy
1
OM 89
1
Mn-PyC3A
1
Medical Marijuana
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Ipilimumab
1
Interferon beta-1a
1
Injections
1
Gadolinium DTPA
1
Fish Oils
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Multiple Sclerosis
×
Interferon beta-1b
×
Clear all
NCT02486640
2023-07-24
BETAPREDICT
Bayer
Completed
162 enrolled
NCT03134573
2019-03-26
PROmyBETAapp
Bayer
Completed
96 enrolled